Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.11B |
| 2 |
Snowflake
SNOW
|
+$1.67B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.61B |
| 4 |
Shopify
SHOP
|
+$1.42B |
| 5 |
Royalty Pharma
RPRX
|
+$1.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$2.27B |
| 2 |
Amazon
AMZN
|
+$2.09B |
| 3 |
Vipshop
VIPS
|
+$1.28B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.27B |
| 5 |
Alibaba
BABA
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Healthcare | 9.78% |
| 3 | Financials | 9.01% |
| 4 | Communication Services | 8.96% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NP
3726
DELISTED
Neenah, Inc. Common Stock
NP
| $3.44M | ﹤0.01% |
66,874
+8,535
| +15% | +$474K |
|
|
XENT
3727
DELISTED
Intersect ENT, Inc
XENT
| $3.44M | ﹤0.01% |
164,467
-8,618
| -5% | -$199K |
|
3728
Digi International
DGII
$3.23B
| $3.43M | ﹤0.01% |
180,373
+38,165
| +27% | +$791K |
|
3729
DNOW Inc
DNOW
$2.97B
| $3.42M | ﹤0.01% |
339,146
-675,949
| -67% | -$6.61M |
|
|
IGI
3730
Western Asset Investment Grade Defined Opportunity Trust
IGI
$95.4M
| $3.42M | ﹤0.01% |
159,687
-6,783
| -4% | -$146K |
|
3731
Carriage Services
CSV
$579M
| $3.42M | ﹤0.01% |
97,153
+29,837
| +44% | +$1.04M |
|
3732
StepStone Group
STEP
$4.15B
| $3.42M | ﹤0.01% |
96,848
+52,235
| +117% | +$1.84M |
|
3733
Acco Brands
ACCO
$401M
| $3.41M | ﹤0.01% |
404,534
-24,877
| -6% | -$214K |
|
3734
Nuveen Real Asset Income & Growth Fund
JRI
$349M
| $3.41M | ﹤0.01% |
231,934
-36,996
| -14% | -$520K |
|
|
WLL
3735
DELISTED
Whiting Petroleum Corporation
WLL
| $3.41M | ﹤0.01% |
96,321
-343,594
| -78% | -$10.3M |
|
|
RNAM
3736
DELISTED
Avidity Biosciences
RNAM
| $3.41M | ﹤0.01% |
156,540
+89,317
| +133% | +$2.19M |
|
3737
ALPS Strategic Income Fund
RIGS
$60.5M
| $3.41M | ﹤0.01% |
138,279
-130,797
| -49% | -$3.23M |
|
|
STSA
3738
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $3.41M | ﹤0.01% |
577,022
-416,601
| -42% | -$2.52M |
|
3739
Benchmark Electronics
BHE
$2.94B
| $3.4M | ﹤0.01% |
110,013
-29,847
| -21% | -$855K |
|
|
NAGE
3740
Niagen Bioscience
NAGE
$239M
| $3.4M | ﹤0.01% |
363,644
-358,581
| -50% | -$2.84M |
|
|
GAM
3741
General American Investors Company
GAM
$1.61B
| $3.39M | ﹤0.01% |
85,200
-4,187
| -5% | -$161K |
|
|
MPV
3742
Barings Participation Investors
MPV
$175M
| $3.39M | ﹤0.01% |
262,183
+25,546
| +11% | +$313K |
|
|
NMY
3743
DELISTED
Nuveen Maryland Quality Municipal Income Fund
NMY
| $3.38M | ﹤0.01% |
239,066
-15,136
| -6% | -$212K |
|
3744
CorVel
CRVL
$3.32B
| $3.38M | ﹤0.01% |
98,976
-18,591
| -16% | -$647K |
|
|
EGIO
3745
DELISTED
Edgio, Inc. Common Stock
EGIO
| $3.38M | ﹤0.01% |
23,677
-19,290
| -45% | -$3.01M |
|
3746
ProShares DJ Brookfield Global Infrastructure ETF
TOLZ
$176M
| $3.38M | ﹤0.01% |
77,663
+4,810
| +7% | +$202K |
|
3747
Manchester United
MANU
$4.17B
| $3.37M | ﹤0.01% |
214,358
+111,609
| +109% | +$1.89M |
|
|
MYD
3748
DELISTED
BlackRock MuniYield Fund
MYD
| $3.37M | ﹤0.01% |
234,819
-2,545
| -1% | -$36.4K |
|
3749
WisdomTree Europe Quality Dividend Growth Fund
EUDG
$69.9M
| $3.36M | ﹤0.01% |
107,477
-28,281
| -21% | -$878K |
|
3750
Northern Oil and Gas
NOG
$2.61B
| $3.36M | ﹤0.01% |
277,974
+60,758
| +28% | +$728K |
|
Similar funds
Morgan Stanley's Q1 2021 Portfolio in Review
As of Q1 2021, Morgan Stanley held 7,749 positions worth $681B, up 5.1% from $647B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q1 2021 filing shows 618 new, 3,173 increased, 3,213 reduced and 188 closed positions. Its largest new stake was Coupang: 16,573,913 shares worth $818M. The largest sale was Paramount Global Class B, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2021 buy was Coupang: 16,573,913 shares worth $818M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $3.11B increase.
- Morgan Stanley's biggest Q1 2021 reduction was Paramount Global Class B, cutting an estimated $2.27B.
- Morgan Stanley fully exited Tiffany & Co. in Q1 2021, selling an estimated $318M.
- Morgan Stanley's ten largest holdings make up 16% of its $681B portfolio in Q1 2021.
- Morgan Stanley opened 618 new positions and closed 188 in Q1 2021.
- Morgan Stanley's portfolio value rose 5.1% quarter-over-quarter to $681B.
Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.